US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 55.100
  • +1.230+2.28%
Close Oct 11 16:00 ET
  • 55.100
  • 0.0000.00%
Post 16:01 ET
5.08BMarket Cap-7642P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
35.75%147.03M
8.30%108.83M
19.52%434.25M
23.27%127.39M
8.10%98.05M
21.23%108.31M
25.72%100.5M
3.39%363.33M
23.93%103.35M
11.09%90.7M
Operating revenue
35.75%147.03M
8.30%108.83M
19.52%434.25M
23.27%127.39M
8.10%98.05M
21.23%108.31M
25.72%100.5M
3.39%363.33M
23.93%103.35M
11.09%90.7M
Cost of revenue
114.65%21.28M
43.04%17.53M
59.64%45.21M
126.57%12.05M
27.30%10.99M
19.88%9.91M
100.93%12.26M
76.91%28.32M
51.58%5.32M
106.73%8.63M
Gross profit
27.80%125.75M
3.47%91.3M
16.13%389.04M
17.66%115.34M
6.08%87.07M
21.37%98.4M
19.51%88.24M
-0.12%335.01M
22.72%98.03M
5.94%82.07M
Operating expense
-1.72%242.11M
5.90%256.65M
-2.61%958.25M
-2.57%237.39M
-24.41%232.16M
10.64%246.35M
15.15%242.34M
37.20%983.93M
33.55%243.66M
83.59%307.14M
Selling and administrative expenses
-0.98%80.6M
1.98%78.16M
11.38%309.8M
5.47%76.83M
7.27%74.92M
19.47%81.4M
13.87%76.65M
26.44%278.14M
22.58%72.85M
29.62%69.84M
Research and development costs
-2.09%161.5M
7.72%178.49M
-8.12%648.45M
-6.00%160.56M
-33.73%157.25M
6.74%164.95M
15.75%165.7M
41.97%705.79M
38.85%170.81M
109.23%237.3M
Operating profit
21.35%-116.36M
-7.30%-165.35M
12.28%-569.21M
16.19%-122.05M
35.53%-145.1M
-4.49%-147.96M
-12.79%-154.11M
-69.99%-648.92M
-41.99%-145.63M
-150.55%-225.07M
Net non-operating interest income expense
9.05%-8.56M
24.86%-7.02M
-23.09%-39.32M
9.31%-8.78M
-6.91%-11.78M
-82.63%-9.41M
-53.46%-9.35M
-16.17%-31.94M
-187.63%-9.68M
-33.20%-11.02M
Non-operating interest income
24.09%7.4M
40.29%8.82M
141.00%26.69M
38.00%8.55M
68.85%5.88M
563.40%5.96M
1,173.28%6.29M
474.38%11.07M
1,308.64%6.2M
753.68%3.48M
Non-operating interest expense
3.80%15.96M
1.35%15.85M
53.44%66M
9.16%17.33M
21.79%17.67M
154.05%15.38M
137.48%15.64M
46.20%43.02M
317.30%15.87M
67.05%14.51M
Other net income (expense)
-236.81%-5.82M
8,334.62%2.14M
100.29%60K
94.65%3.93M
22.45%-2.12M
84.45%-1.73M
99.71%-26K
52.31%-20.87M
112.24%2.02M
-110.80%-2.73M
Gain on sale of security
-1,629.12%-3.99M
1,221.56%3.75M
102.06%397K
2.66%1.89M
12.73%-1.42M
102.56%261K
96.42%-334K
54.12%-19.3M
111.43%1.84M
-106.33%-1.63M
Other non- operating income (expenses)
8.04%-1.83M
-621.10%-1.61M
78.48%-337K
1,035.00%2.04M
36.74%-699K
-113.87%-1.99M
6.57%308K
7.17%-1.57M
143.90%180K
-166.27%-1.11M
Income before tax
17.82%-130.74M
-4.13%-170.23M
13.29%-608.46M
17.22%-126.89M
33.42%-159M
-0.78%-159.1M
-7.72%-163.48M
-54.91%-701.73M
-25.19%-153.28M
-227.98%-238.82M
Income tax
17.21%858K
-8.08%455K
-132.04%-1.83M
-155.13%-3.7M
-89.66%650K
142.38%732K
-11.29%495K
445.59%5.7M
-7,355.00%-1.45M
3,354.40%6.29M
Net income
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
Net income continuous Operations
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
Minority interest income
Net income attributable to the parent company
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.66%-131.6M
-4.09%-170.68M
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
Basic earnings per share
32.44%-1.52
12.88%-2.03
18.48%-8.25
29.63%-1.52
36.29%-2.23
0.44%-2.25
-6.39%-2.33
-51.04%-10.12
-20.67%-2.16
-224.07%-3.5
Diluted earnings per share
32.44%-1.52
12.88%-2.03
18.48%-8.25
29.63%-1.52
36.29%-2.23
0.44%-2.25
-6.39%-2.33
-51.04%-10.12
-20.67%-2.16
-224.07%-3.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 35.75%147.03M8.30%108.83M19.52%434.25M23.27%127.39M8.10%98.05M21.23%108.31M25.72%100.5M3.39%363.33M23.93%103.35M11.09%90.7M
Operating revenue 35.75%147.03M8.30%108.83M19.52%434.25M23.27%127.39M8.10%98.05M21.23%108.31M25.72%100.5M3.39%363.33M23.93%103.35M11.09%90.7M
Cost of revenue 114.65%21.28M43.04%17.53M59.64%45.21M126.57%12.05M27.30%10.99M19.88%9.91M100.93%12.26M76.91%28.32M51.58%5.32M106.73%8.63M
Gross profit 27.80%125.75M3.47%91.3M16.13%389.04M17.66%115.34M6.08%87.07M21.37%98.4M19.51%88.24M-0.12%335.01M22.72%98.03M5.94%82.07M
Operating expense -1.72%242.11M5.90%256.65M-2.61%958.25M-2.57%237.39M-24.41%232.16M10.64%246.35M15.15%242.34M37.20%983.93M33.55%243.66M83.59%307.14M
Selling and administrative expenses -0.98%80.6M1.98%78.16M11.38%309.8M5.47%76.83M7.27%74.92M19.47%81.4M13.87%76.65M26.44%278.14M22.58%72.85M29.62%69.84M
Research and development costs -2.09%161.5M7.72%178.49M-8.12%648.45M-6.00%160.56M-33.73%157.25M6.74%164.95M15.75%165.7M41.97%705.79M38.85%170.81M109.23%237.3M
Operating profit 21.35%-116.36M-7.30%-165.35M12.28%-569.21M16.19%-122.05M35.53%-145.1M-4.49%-147.96M-12.79%-154.11M-69.99%-648.92M-41.99%-145.63M-150.55%-225.07M
Net non-operating interest income expense 9.05%-8.56M24.86%-7.02M-23.09%-39.32M9.31%-8.78M-6.91%-11.78M-82.63%-9.41M-53.46%-9.35M-16.17%-31.94M-187.63%-9.68M-33.20%-11.02M
Non-operating interest income 24.09%7.4M40.29%8.82M141.00%26.69M38.00%8.55M68.85%5.88M563.40%5.96M1,173.28%6.29M474.38%11.07M1,308.64%6.2M753.68%3.48M
Non-operating interest expense 3.80%15.96M1.35%15.85M53.44%66M9.16%17.33M21.79%17.67M154.05%15.38M137.48%15.64M46.20%43.02M317.30%15.87M67.05%14.51M
Other net income (expense) -236.81%-5.82M8,334.62%2.14M100.29%60K94.65%3.93M22.45%-2.12M84.45%-1.73M99.71%-26K52.31%-20.87M112.24%2.02M-110.80%-2.73M
Gain on sale of security -1,629.12%-3.99M1,221.56%3.75M102.06%397K2.66%1.89M12.73%-1.42M102.56%261K96.42%-334K54.12%-19.3M111.43%1.84M-106.33%-1.63M
Other non- operating income (expenses) 8.04%-1.83M-621.10%-1.61M78.48%-337K1,035.00%2.04M36.74%-699K-113.87%-1.99M6.57%308K7.17%-1.57M143.90%180K-166.27%-1.11M
Income before tax 17.82%-130.74M-4.13%-170.23M13.29%-608.46M17.22%-126.89M33.42%-159M-0.78%-159.1M-7.72%-163.48M-54.91%-701.73M-25.19%-153.28M-227.98%-238.82M
Income tax 17.21%858K-8.08%455K-132.04%-1.83M-155.13%-3.7M-89.66%650K142.38%732K-11.29%495K445.59%5.7M-7,355.00%-1.45M3,354.40%6.29M
Net income 17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M
Net income continuous Operations 17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M
Minority interest income
Net income attributable to the parent company 17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.66%-131.6M-4.09%-170.68M14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M
Basic earnings per share 32.44%-1.5212.88%-2.0318.48%-8.2529.63%-1.5236.29%-2.230.44%-2.25-6.39%-2.33-51.04%-10.12-20.67%-2.16-224.07%-3.5
Diluted earnings per share 32.44%-1.5212.88%-2.0318.48%-8.2529.63%-1.5236.29%-2.230.44%-2.25-6.39%-2.33-51.04%-10.12-20.67%-2.16-224.07%-3.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data